GlassScriptPhysician profile
Sharon Ben-Or
NPI 1639369887
$14,961.43
in general payments reported to CMS, 2019-2025
15 companies · $995 in 2025
The $995 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $5,533 · 2021: $7,101 · 2022: $337 · 2023: $281 · 2024: $494 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124 · Travel and Lodging: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.25 |
| Travel and Lodging | $645.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $7,393.12 | 2020-2021 | |
| Medical Device Business Services, INC. | $4,727.01 | 2021 | |
| Intuitive Surgical, INC. | $921.45 | 2021-2025 | |
| Atricure, INC. | $527.56 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Astrazeneca Pharmaceuticals LP | $287.29 | 2024-2025 | Tagrisso |
| Ethicon INC. | $227.76 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $203.17 | 2021-2022 | |
| Medtronic, INC. | $121.14 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $114.17 | 2024 | |
| Pinnacle Biologics, INC | $98.10 | 2019 | |
| Boston Scientific Corporation | $86.05 | 2021 | |
| Depuy Synthes Sales INC. | $83.82 | 2022 | |
| Tela Bio, INC. | $81.13 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $65.66 | 2024-2025 | Vistaseal, Echelon Flex, Harmonic |
| Solventum Corporation | $24.00 | 2024 | Activ.A.C., Adaptic, V.A.C. Dermatac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Ben-Or listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.